Safety and Efficacy of DIDALA Monotherapy in Patients With Type 2 Diabetes Compared With Metformin.

Exclusion Criteria

• •The patient has been diagnosed with diabetes and has been previously treated with metformin or other antidiabetic agents.
• •Patients with indications for insulin therapy or combination therapy of two or more drugs according to the guidelines for diagnosis and treatment of type 2 diabetes of the Ministry of Health.
• •Pregnancy or lactation.
• •Patients with contraindications to Metformin include severe liver and/or kidney disease, congestive heart failure, cardiovascular collapse, acute myocardial infarction, severe infection, and sepsis.
• •Patients with conditions and circumstances that, in the investigator's opinion, are difficult to ensure adherence to study protocol.